Tthe brokerage has downward revised its FY21 and FY22 forecasts on Cipla, having knocked off Voltaren sales number and pushed Albuterol inh...

The executives have to frequent the city to record statements or make submissions before authorities.

The tax heads of firms such as Novartis India, Sun Pharma, Cipla, Lupin have been summoned for meetings with tax officials, they said.

Tax experts said previous rulings allowed companies to have a combined Cenvat credit. However, there were also some rulings that allowed su...

Short covering in IT and pharma stocks on weak rupee led to the indices close on a positive note.

NPPA has sent show-cause notices to these companies alleging overcharging for the combination drug used to treat the potentially fatal Hepa...

Though there is a hope of reduction in taxation and direct tax reforms, the weekend statement is getting a lot of HNI community worried, sa...

The biggest play is going to be over a longer period of time all those Indian corporates who have ventured into the defence after the polic...

The CBDT has set a target of Rs 2.56 trillion for Mumbai region, the largest tax region which contributes over a third of the total tax rev...

The Sensex ended the day at 27,490.59; up 479.28 points. The broader 50-share Nifty closed the session at 8,331.95; up 150.45 points.

The S&P BSE Sensex ended the day at 27,437.94; down 297.08 points. The broader 50-share Nifty closed the session at 8,305.25; down 93.05 po...

Mumbai based pharmaceutical giant Cipla came under the scanner of the income tax authorities for alleged tax evasion.

Pharmaceutical companies are expected to post core profit growth of over 15 per cent, year-on-year, for the quarter ended December 2013.

Indian markets are likely to trade in a range. Here is a list of ten stocks which are likely to remain in focus in morning trade.

Vaibhav Sankla, Executive Director, Adroit helps with your tax planning.

Sikkim, which is the least populous state in the country and the second-smallest after Goa, has already attracted pharma investment upwards...

India’s pharmaceutical industry, which is troubled by the appreciating rupee and market challenges abroad, is hoping that the finance minis...